Bluejay Diagnostics Files S-1 for Public Offering

TL;DR

Bluejay Diagnostics just filed an S-1, looks like they're gearing up for an IPO.

AI Summary

Bluejay Diagnostics, Inc. filed an S-1 registration statement on June 17, 2024, to register securities under the Securities Act of 1933. The company, incorporated in Delaware with its principal executive offices at 360 Massachusetts Avenue, Suite 203, Acton, MA 01720, operates in the surgical and medical instruments and apparatus industry. The filing indicates a potential public offering, though specific dollar amounts and dates for the offering are not detailed in this initial document.

Why It Matters

This S-1 filing signals Bluejay Diagnostics' intention to go public, which could bring new investment into the medical device sector and offer investors a chance to participate in the company's growth.

Risk Assessment

Risk Level: medium — As an S-1 filing, it represents a company seeking to raise capital through a public offering, which inherently carries market and execution risks not yet fully disclosed.

Key Numbers

• 3841 — SIC Code (Indicates the company operates in the Surgical & Medical Instruments & Apparatus industry.)
• 473552922 — EIN (Employer Identification Number for Bluejay Diagnostics, Inc.)

Key Players & Entities

• Bluejay Diagnostics, Inc. (company) — Registrant
• June 17, 2024 (date) — Filing Date
• 360 Massachusetts Avenue, Suite 203, Acton, MA 01720 (location) — Principal Executive Offices
• 3841 (industry_code) — Standard Industrial Classification
• 473552922 (tax_id) — IRS Employer Identification Number
• 333-280253 (filing_number) — SEC File Number

FAQ

Key Financial Figures

• $0.0001 — ne share of our common stock, par value $0.0001 per share (the “common stock&rdqu
• $0 — luding one share of common stock, minus $0.0001, and the remaining exercise price
• $75,000 — -accountable expense allowance equal to $75,000. See “Underwriting” for a d

Filing Documents

• ea0207908-s1_bluejay.htm (S-1) — 550KB
• ea020790801ex1-1_bluejay.htm (EX-1.1) — 254KB
• ea020790801ex4-11_bluejay.htm (EX-4.11) — 129KB
• ea020790801ex4-12_bluejay.htm (EX-4.12) — 137KB
• ea020790801ex4-13_bluejay.htm (EX-4.13) — 117KB
• ea020790801ex23-1_bluejay.htm (EX-23.1) — 2KB
• ea020790801ex-fee_bluejay.htm (EX-FILING FEES) — 21KB
• image_001.jpg (GRAPHIC) — 4KB
• 0001213900-24-053132.txt ( ) — 1216KB

UNDERWRITING

UNDERWRITING 29 LEGAL MATTERS 33 EXPERTS 33 INFORMATION INCORPORATED BY REFERENCE 33 WHERE YOU CAN FIND ADDITIONAL INFORMATION 34 i ABOUT THIS PROSPECTUS The registration statement of which this prospectus forms a part that we filed with the Securities and Exchange Commission (the “SEC”) includes exhibits that provide more detail of the matters discussed in this prospectus. You should read this prospectus and the related exhibits filed with the SEC, together with the additional information described under the headings “Where You Can Find Additional Information” and “Information Incorporated by Reference” before making your investment decision. You should rely only on the information provided in or incorporated by reference in this prospectus, in any prospectus supplement or in a related free writing prospectus, or documents to which we otherwise refer you. In addition, this prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. This prospectus includes important information about us, the securities being offered and other information you should know before investing in our securities. You should not assume that the information contained in this prospectus is accurate on any date subsequent to the date set forth on the front cover of this prospectus, even though this prospectus is delivered or securities are sold or otherwise disposed of on a later date. It is important for you to read and consider all information contained in this prospectus in making your investment decision. All of the summaries in this prospectus are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a part, and you may obtain copies